Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03222609 |
|---|---|
| Brief Title: | A Study Evaluating Tolerability and Efficacy of Navitoclax Alone or in Combination With Ruxolitinib in Participants With Myelofibrosis (REFINE) |
| First Submitted : | July 17, 2017 |
| First Submitted that Met QC Criteria : | July 17, 2017 |
| First Posted : | July 19, 2017 |
| Certification/Extension First Submitted : | March 1, 2023 |
| Certification/Extension First Posted : | March 3, 2023 |
| Last Update Submitted that Met QC Criteria : | March 1, 2023 |
| Last Update Posted : | March 3, 2023 |